The pharmaceutical company has forged a partnership with the nanotechnology specialist to use nanoparticle tech and formulation to advance its products.
The two companies plan to collaboratively explore ways to combine 3D printing and nanotechnology, in order to create nanoparticle-enabled dosage forms.
On May 5, the Innovations in Drug Delivery webinar will feature views on trends and technology from AstraZeneca, i20 Therapeutics, and top researchers.
Scancell and Cancer Research UK use nanodelivery technology to activate the body’s immune system, boosting its ability to target and destroy cancer cells.
The United States Food and Drug Administration (FDA) has announced it will consider products outside the nanoscale, up to 1,000 nanometres (nm), to involve nanotechnology and so be potentially liable for “particular examination.”
Scientists at UCF (University of Central Florida) believe they have found a simpler and more efficient way to mass produce the structured nanoparticles used for drug delivery and production.
GlaxoSmithKline (GSK) has urged the US FDA consider the absorption of nanomaterials in the gastrointestinal (GI) tract within its proposal for new regulations on nanotechnology.
Nano Terra, a surface engineering and nanotechnology company based in Brighton Massachusetts, US, has struck a deal to acquire neighbouring drug developer, Surface Logix.
BioNano Consulting (BNC) predicts impending patent loss will accelerate adoption of nanotechnology in drug formulation and head to US to boost US business.
The potential of microbial cells as producers of nanomaterials has been underestimated and further research is needed to improve the situation, according to an academic.
Particle Sciences (PSI) is aiming to advance its contract processing offering by collaborating with Microfluidics and sharing formulation and nanotechnology expertise.
This week in-PharmaTechnologist's Pharma Phacts podcast focuses on a nanotechnology method that could produce more effective barrier packaging using less material.
The US Food and Drug Administration (FDA) is seeking feedback from the pharmaceutical industry to develop the recommendations of the Nanotechnology Task Force.
Germany's Capsulution Nanoscience is tapping into Qiagen's
molecular diagnostics expertise in a collaboration that will
explore new diagnostic and therapeutic possibilities for cancer and
other diseases.
MFIC is looking to introduce a new microfluidic system that
could help pharmaceutical and biotechnology companies to
manufacture difficult to formulate drugs.
A transdermal patch for needle-free delivery of insulin and a
diagnostic test for rapid detection of meningococcal disease are
among the products under development by two new Australian
companies set up to commercialise the research...
UK research organisations, biopharmaceutical and food
manufacturers, along with those in other industries are been asked
to voluntarily provide any information on nanotechnologies they are
working on, under a programme launched this...
A new report warns that as nanotechnology becomes a reality, Europe
must not miss the boat, and raises the alarm that the potential
benefits of nanomedicine in Europe will be lost without major
investment in R&D.
A newly signed research and collaboration agreement between MFIC
Corporation and The University of Massachusetts Lowell (UML) will
facilitate the development of new applications, processes and
products in the growing area of nanomaterials.
According to a new report nanotechnology tools for drug discovery
will grow from $580 million (€471.6 million) in 2004 to $1.1
billion in 2010, driven by corporate R&D and new commercial
applications.
A recent report claims that nanobiotechnology is under growing
pressure to fulfil its potential and repay the private and public
funding that has been invested towards this emerging science
sector.
Nanogen has been issued with a European patent, which relates to a
nanofabrication technology combining a manufacturing platform and
nanostructures that is set to broaden Nanogen's position in the
nanotechnology and nanomanufacturing...
According to a new report, nanotechnology is set to play a major
part in drug delivery systems especially for tumour therapies. The
report cites nanoparticles as being particularly suited to curing
specific conditions such as cancer,...
The emergence of nanotechnology is likely to have a significant
impact on drug delivery sector, affecting just about every route of
administration from oral to injectable, according to specialist
market research firm NanoMarkets.
Japanese company GSI Creos has unveiled the first prototype of a
new cell culture reactor that uses nanotechnology to support the
growth of more cells than conventional reactors. The bioreactor
could potentially boost the yield of...
The top pharmaceutical companies are investing less money and
people in nanotechnology than other industries, despite pressure to
replace fading blockbuster drugs as fewer drugs come out of the
sector's R&D pipeline, according...
The German government is the latest in Europe to start a programme
to support companies and academics working in the emerging field of
'bionanotechnology'.
A new European project on the emerging discipline of
nanobiotechnology aims to tackle the thorny issue of safety as well
as develop new materials for drug delivery and other medical uses,
reports Phil Taylor.
A report by the UK's Health and Safety Executive has concluded that
the safety of the tiny particles created by the emerging
nanotechnology industry has not been fully assessed.
The European Commission has started a discussion on its strategy
for developing Europe's nanotechnology industry, and is seeking
comments on its proposals put forward in June.
US firm Altair Nanotechnologies has filed two new patent
applications on its TiNano Spheres drug delivery system, which it
claims can deliver a large amount of drug, improving reaction
rates.
The UK's Science and Innovation Minister, Lord Sainsbury, has
defended his government's record on nanotechnology, after last
week's report from the House of Commons science and technology
select committee blamed policy...
Leaving aside the safety concerns surrounding nanotechnology set
out in In-Pharmatechnologist.com's lead article today, a
report commissioned by the UK government has claimed that a lack of
foresight by both policy makers and...
Microfluidics has launched the first research-scale versions of its
patented High-Pressure Multiple Stream Mixer Reactor (MMR), claimed
to create uniform particles smaller than anything achieved using
current technologies.
The US has passed a new bill that will see the country invest €3.1
billion in nanotechnology over the next four years and should
cement its position as a leader in this emerging technology sector.
Sweden's Nanoxis has secured a financing deal that will help it
develop nanoanalytical platforms - so-called proteinchips - for the
identification of proteins in drug discovery.
The UK has launched a new study to examine in detail the benefits
and risks of nanotechnology and make sure that any necessary
regulatory framework is in place early on
France needs to invest more in the emerging 'revolutionary' science
of nanotechnologies if it is to remain competitive in this
promising field, a French parliamentary committee has recommended.
